About Emtech Bio

A B O U T E M T E C H B I O

Emtech Biotechnology Development, Inc. (Emtech Bio), jointly established by Emory University and the Georgia Institute of Technology, converts science to business through translational research and business incubation. Emtech Bio currently houses five biotech companies:

GeoVax Labs, Inc., a clinical stage biotechnology company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus-AIDS) and other infectious agents

NeurOp Corporation, a preclinical stage pharmaceutical company focused on next generation of small molecule drugs for central nervous system (CNS) indications

Zetra Biologicals, LLC, a preclinical stage biopharmaceutical company developing innovative vaccines against pandemic influenza and other infectious diseases

Effigene Pharmaceuticals, Inc., a preclinical stage biopharmaceutical company developing small interference RNA (siRNA)-based therapeutics to treat various human diseases

Renovo Research, LLC, a drug discovery service provider developing/screening cocrystals of pharmaceuticals

Emtech Bio promotes company interaction by providing common meeting areas and development of business skills by hosting lunch-time seminars featuring speakers with expertise in relevant business fields such as Venture Capital, Public Relations and Intellectual Property Management.

In addition to laboratory space and business support programs for its affiliated companies, Emtech Bio supports a competitive grant program for Emory and Georgia Tech faculty. This program funds research with realizable commercial potential. The Emtech Bio grant program is now in its eighth year and is funded equally by Emory and Georgia Tech. The most recent request for proposals yielded 8 submissions. The Emtech Bio scientific advisory board chaired by Dr. Robert Nerem, Director of the Petit Institute for Bioengineering and Bioscience at Georgia Tech, is charged with review of these proposals.

Funding for the Emtech facility and much of the scientific equipment was provided by the state of Georgia through the Georgia Research Alliance.

Emtech's governing body is a four-person Board of Trustees, with two members appointed by the President of each founding university. A management contract with ATDC (the Advanced Technology Development Center) allows a lean executive staff by providing highly experienced management talent on a part-time basis. Both Emory and Georgia Tech provide legal and financial advisors.

For more information on the Emtech Bio organization, please contact:

Emtech Bio
Phone Number: 404-727-2514
Email Address: ott-web@emory.edu

Mailing address:
Emtech Bio
1256 Briarcliff Road NE
Atlanta, GA 30306
Phone Number: 404-727-4518

Todd Sherer, President
1599 Clifton Road, 4th Floor
Atlanta, GA 30322
Phone Number: 404-727-4518
Email address: Todd@emtechbio.com